Pharmafile Logo

Hope in cancer therapy

The future looks hopeful as second-generation radiopharmaceuticals venture into uncharted territories.

- PMLiVE

The use of systemic radioactive medications as cancer therapies dates back to the 1940s when radioactive iodine was employed to treat thyroid cancer. However, due to their limited potency and side effects, radiopharmaceuticals were largely sidelined.

The landscape changed with the introduction of commercially available antibody-directed radiotherapeutics in the early 2000s, marked by the approval of Zevalin and Bexxar. Despite this progress, challenges such as the requirement for specialized facilities, equipment, and expertise hindered their widespread adoption.

Recent developments in the field have ushered in a new era for radiopharmaceuticals. Biopharma Dealmakers, a publication by Nature, highlights the significant advancements made with second-generation marvels like Xofigo and Pluvicto.

Read the full article on our Biopharma Dealmakers website.

To reach potential partners and investors for your cancer therapies, contact us about advertising with Biopharma Dealmakers.

This content was provided by Springer Nature

Company Details

 Latest Content from  Springer Nature 

Hope in cancer therapy

The future looks hopeful as second-generation radiopharmaceuticals venture into uncharted territories.

Health awareness days in May

Are you marketing to clinical audiences around upcoming health awareness days?

Advertise to healthcare professionals with Springer Nature

Reach physicians and other HCPs with the publisher, Springer Nature

How to create content for health professionals

Catching the attention of time-strapped healthcare professionals is hard, but not impossible.

[Free Report] The What, How, and When of creating content for oncologists

Create content marketing that really engages healthcare professionals.

[Free Report] Optimizing content marketing for cardiologists

Use the Springer Nature report to create content that really engages your audience of healthcare professionals.